Finance

Lists
9630:TADAWUL
Ratio Specialty Company CJSC
2,40 SAR
0,00%
(0,00) 1D
12-окт., 14:41:52 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9630...
Mkt. cap
48,00 млн
Avg. vol.
10,09 миң
Volume
1,83 миң
52-wk high
8,10 SAR
52-wk low
2,39 SAR
EPS
-0,15 SAR
Shares outstanding
15,95 млн
Mkt. cap
48,00 млн
Avg. vol.
10,09 миң
Volume
1,83 миң
52-wk high
8,10 SAR
52-wk low
2,39 SAR
EPS
-0,15 SAR
Shares outstanding
15,95 млн
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
58 мүнөт мурун
Iambic Therapeutics raises USD 150m in Nasdaq IPO
Yahoo Finance
Yahoo Finance
·
47 мүнөт мурун
3 S&P 500 Stocks We Steer Clear Of
About Ratio Specialty Company CJSC
CEO-
Employees-
Founded2014
Headquarters-
Sector-
Websiteratio.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
13,97 млн
13,97 млн
14,10 млн
14,10 млн
Cost of goods sold
10,67 млн
10,67 млн
11,76 млн
11,76 млн
Cost of revenue
10,67 млн
10,67 млн
11,76 млн
11,76 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,39 млн
2,39 млн
2,13 млн
2,13 млн
Operating expense
3,66 млн
3,66 млн
3,04 млн
3,04 млн
Total operating expenses
14,33 млн
14,33 млн
14,80 млн
14,80 млн
Operating income
-357,43 миң
-357,43 миң
-703,02 миң
-703,02 миң
Other non operating income
-135,50 миң
-135,50 миң
73,62 миң
73,62 миң
EBT including unusual items
-700,52 миң
-700,52 миң
-605,58 миң
-605,58 миң
EBT excluding unusual items
-504,58 миң
-504,58 миң
-629,39 миң
-629,39 миң
Income tax expense
28,08 миң
28,08 миң
139,37 миң
139,37 миң
Effective tax rate
-4,01%
-4,01%
-23,01%
-23,01%
Other operating expenses
-
-
-
-
Net income
-728,60 миң
-728,60 миң
-744,96 миң
-744,96 миң
Net profit margin
-5,22%
-5,22%
-5,28%
-5,28%
Earnings per share
-
-
-
-
Interest and investment income
42,77 миң
42,77 миң
-
-
Interest expense
-54,41 миң
-54,41 миң
-
-
Net interest expenses
-11,64 миң
-11,64 миң
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
292,91 миң
292,91 миң
310,24 миң
310,24 миң
Gain or loss from assets sale
195,95 миң
195,95 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору